Details for 2017184486
Up to date per 02.04.2026
Actions
Details for 2017184486
Granted/Registered
European Patent
04.04.2018 A
25.03.2020 B1
18.11.2011
US
201161561710 P
26.03.2012
US
201261615618 P
06.08.2012
US
201261680098 P
C12N 15/113 20100101AFI20180122BHEP
Owner
Alnylam Pharmaceuticals, Inc.300 Third Street, 3rd Floor Cambridge, MA 02142US
Representative
Representative
Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
KALLANTHOTTATHIL, Rajeev G.c/o Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor Cambridge, MA Massachusetts 02142US
ZIMMERMANN, Tracyc/o Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor Cambridge, MA Massachusetts 02142US
MANOHARAN, Muthiahc/o Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor Cambridge, MA Massachusetts 02142US
MAIER, Martinc/o Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor Cambridge, MA Massachusetts 02142US
KUCHIMANCHI, Satyanarayanac/o Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor Cambridge, MA Massachusetts 02142US
CHARISSE, Klausc/o Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor Cambridge, MA Massachusetts 02142US
Information about Fees